Botanical species · safety record

Magnolia denudata

The EFSA Compendium of Botanicals holds 27 constituent measurements for Magnolia denudata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Magnolia denudata Desr.

27Constituent measurements

0Safety records

11Cited sources

3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Magnolia denudata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Flower

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Flower	Essential oil	≥ 0.5 Percent	Distillation-titrimetry (modified Monier-William method)	Resolve DOI
1,8-cineole	Flower	Essential oil	≤ 2.4 Percent	Distillation-titrimetry (modified Monier-William method)	Resolve DOI
Epi-magnolin a	Bud	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Honokiol	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Lignans	Bud	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Lignans	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Magnoline	Bud	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Magnolol	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Neolignans	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Neolignans	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Phenolic compounds	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Tyramine	Leaves	Solvent extraction	8 Milligram/100 gram	Nuclear Magnetic Resonance (NMR)	Resolve DOI
(+)-epieudesmine	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
1,8-cineole	—	Essential oil	16.52 Percent	GC*GC/MS	No resolvable identifier
1,8-cineole	Flower	Solvent extraction	≤ 11.2 Percent	GC-MS	No resolvable identifier
1,8-cineole	Flower	Solvent extraction	≥ 4.9 Percent	GC-MS	No resolvable identifier
Asarinin	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Beta-eudesmol	—	Essential oil	4.8 Percent	GC*GC/MS	No resolvable identifier
Costunolide	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Kobusin	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Lutein epoxide	Bud	—	—	—	No resolvable identifier
Myrcene	—	Essential oil	8.49 Percent	GC*GC/MS	No resolvable identifier
Neolignans	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Parthenolide	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Phenylpropanoids	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Pinoresinol	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Violaxanthin	Bud	—	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Garcia-Plazaola, Jose I., Hormaetxe, Koldobika., Hernandez, Antonio., Olano, Jose M., Becerril, Jose M. The lutein epoxide cycle in vegetative buds of woody plants. Functional plant biology, 2004, vol. 31, no. 8, p. 815-823.
Lei, Gaoming., Zhang, Anyun., Liu, Xuesong., Wang, Longhu. Study on the recovered essential oil obtained from hydrosol of Yulania denudata fresh flowers . Journal of essential oil research, 2015, vol. 27, no. 2, p. 153-159. DOI
Zhang, Jian., Sun, Peilong., Xu, Shuangyang., Yang, Kai. Chemical constituents in essential oil from Magnolia denudata Desr.. Jingxi huagong, 2006, vol. 23, no. 4), 372-37, p. 396.
Zuma, Hiroshi., Toyota, Masao., Asakawa, Yoshinori., Kawano, Shoichi. Naphthalene- a constituent of Magnolia flowers. Phytochemistry (oxford), 1996, vol. 42, no. 4, p. 999-1004.
Kong, Chang-Suk., Lee, Jung Im., Kim, Jung-Ae., Seo, Youngwan. In Vitro Evaluation on the Antiobesity Effect of Lignans from the Flower Buds of Magnolia denudata . Journal of agricultural and food chemistry, 2011, vol. 59, no. 10, p. 5665-5670. DOI
FUNAYAMA, S., ADACHI, M., AOYAGI, T., NOZOE, S. CYTOCIDAL PRINCIPLES OF MAGNOLIA-DENUDATA. International journal of pharmacognosy, 1995, vol. 33, no. 1, p. 21-24.
Noshita, Toshiro., Kiyota, Hiromasa., Kidachi, Yumi., Ryoyama, Kazuo., Funayama, Shinji., Hanada, Ken., Murayama, Tetsuya. New Cytotoxic Phenolic Derivatives from Matured Fruits of Magnolia denudata . Bioscience biotechnology and biochemistry, 2009, vol. 73, no. 3, p. 726-728. DOI
Noshita, Toshiro., Funayama, Shinji., Hirakawa, Tadayoshi., Kidachi, Yumi., Ryoyama, Kazuo. Machilin G and Four Neolignans from Young Fruits of Magnolia denudata Show Various Degrees of Inhibitory Activity on Nitric Oxide (NO) Production . Bioscience biotechnology and biochemistry, 2008, vol. 72, no. 10, p. 2775-2778. DOI
Chung, Ching-Yi., Kuo, Wen-Lung., Hwang, Tsong-Long., Chung, Mei-Ing., Chen, Jih-Jung. Biphenyl-Type Neolignan Derivatives from the Twigs of Magnolia denudata and Their Anti-Inflammatory Activity . Chemistry & biodiversity, 2015, vol. 12, no. 8, p. 1263-1270. DOI
IIDA, T., ICHINO, K., ITO, K. NEOLIGNANS FROM MAGNOLIA-DENUDATA. Phytochemistry, 1982, vol. 21, no. 12, p. 2939-2941.
MATSUTANI, H., SHIBA, T. TYRAMINE FROM MAGNOLIA SPECIES. Phytochemistry, 1975, vol. 14, no. 4, p. 1132-1133. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature